期刊文献+

MicroRNA-146a抑制胶质瘤细胞增殖的研究 被引量:3

MicroRNA-146a Inhibits the Proliferation of Glioma Cell
原文传递
导出
摘要 目的:检测胶质瘤中miR-146a的表达水平,并研究miR-146a对胶质瘤细胞增殖的影响。方法:应用实时定量PCR的方法检测胶质瘤组织和癌旁组织中miR-146a的表达水平,采用脂质体细胞转染miRNA模拟物的方式过表达miR-146a,MTT法检测转染后细胞的增殖率,利用在线软件targetScan预测miRNA可能的靶基因。结果:miR-146a在胶质瘤组织中表达明显降低(P<0.01),相对表达水平为癌旁组织的35%,细胞转染miR-146a模拟物后,miR-146a表达明显增加,癌细胞增殖率明显降低(P<0.01),仅为原细胞的47%。Notch1基因是miR-146a影响胶质瘤细胞增殖活力的可能靶基因。结论:miR-146a可能通过抑制Notch1基因的表达调控胶质瘤细胞的增殖。 Objective: To investigate the abnormally expression and effect of miR-146a on proliferation in glioma cancer.Methods: Real-Time PCR assay was used to determine the abnormally expression of miR-146a in tumor-adjacent tissues and glioma tissues.The activity of miR-146a was up-regulated by the method of lipofection of the mimic of miR-146a.Real-time PCR was also used to observe the expression level of miR-146a.Cell viability analysis was done by MTT.The targeted genes of miR-146a in glioma were scanned by the online targeted gene prediction software.Results: miR-146a was detected down-regulated in glioma tissues,with 35% for tumor-adja-cent tissues(p0.01).The cell viability was decreased after miR-146a was up-regulated in glioma cell by miR-146a-mimic transfection.Notch1 was the potential targeted gene of miR-146a in glioma.Conclusions: miR-146a could affect the proliferation of glioma cell by in-hibiting the Notch1 expression.
出处 《现代生物医学进展》 CAS 2011年第24期4821-4823,共3页 Progress in Modern Biomedicine
基金 上海浦江人才基金资助项目(08PJ1400400)
关键词 胶质瘤 MIR-146A 细胞增殖 NOTCH1基因 Glioma MiR-146a Cell proliferation Notch1 gene
  • 相关文献

参考文献18

  • 1Furnari FB,Fenton T,Bachoo RM,et al. Malignant astrocytic glioma: genetics,biology, and paths to treatment [J]. Genes Dev,2007,21(21):2683-2710.
  • 2Huse JT, Holland EC. Targeting brain cancer: Advances in the molec- ular pathology of malignant glioma and medulloblastoma[J]. Nat Rev Cancer, 2010,10(5):319-331.
  • 3Muldoon LI, Soussain C,Jahnke K,et al. Chemo-the rapy delivery is- sues in central nervous system malignancy:a reality check [J]. J Clin Oncol,2007,25(16):2295-2305.
  • 4Deeken JF,Losch er W. The blood-brain barrier and cancer:trans- porters,treatment,and Trojan horses [J]. Clin Cancer Res,2007,13 (6): 1663-1674.
  • 5Singh SK,Hawkins C,Clarke ID,et al. Identification of human brain tu- mour initiating ceils [J]. Nature,2004,432(7015):396-401.
  • 6Galli R,Binda E,Orfanelli U,et al. Isolation and characterization of tu- morigenic,stem-like neural precursors from htmaan glioblastoma [J]. Cancer Res,2004,64(19):7011-7021.
  • 7Fu YJ, Du J, Yang R J, Yin LT, Liang AH. Potential adenovirus-medi- ated gene therapy ofglioma cancer [J]. Biotechnology letters,2010,32 (1):11-18.
  • 8Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and func- tion[J]. CeU,2004,116(2):281-297.
  • 9Plasterk RH. MicroRNAs in animal development [J]. Cell, 2006,124 (5): 877-881.
  • 10Kloosterman WP, Plasterk RH. The diverse functions of micromas in animal development and disease [J]. Developmental cell,2006,11 (4): 441-450.

同被引文献34

  • 1Weinberg D G,Arnaout O M, Rahme R J, Aoun S G, Batjer H H, Bendok B R. Moyamoya disease., a review of histopathology, biochemistry, and genetics [J]. Neuro- surg Focus, 2011,30 : E20.
  • 2Duan L,Bao X Y,Yang W Z,Shi W C,Li D S,Zhang Z S,et al. Moyamoya disease in China:its clinical features and outcomes[J].. Stroke, 2012,43 :56-60.
  • 3Wang Y,Wang X,Zhang J,Sun G,Luo H,Kang C,et al. MieroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas[J]. J Neurooncol, 2012, 106: 217- 224.
  • 4Zhao C, Dong J ,Jiang T, Shi Z, Yu B, Zhu Y, et al. Early second-trimester serum miRNA profiling predicts ges- tational diabetes mellitus [J]. PLoS One, 2011, 6: e23925.
  • 5Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse J L,et al. MicroRNAs in plasma of pancreatic ductal ad-enocarcinoma patients as novel blood-based biomarkers of disease[J]. Cancer Prev Res (Phila), 2009,2:807- 813.
  • 6Wang O K,Zhu J Q,Zhang J T,Li Q,Li Y,He J,et al. Circulating microRNA:a novel potential biomarker for early diagnosis of acute myocardial infarction in humans [J]. Eur Heart J,2010,31 :659-666.
  • 7Liu Z,Yang D,Xie P,Ren G,Sun G,Zeng X,et al. MiR- 106b and MiR-15b modulate apoptosis and angiogenesis in myocardial infarction[J]. Cell Physiol Biochem,2012, 29:851-862.
  • 8Taurino C,Miller W H, Mcbride M W, McClure J D, Khanin R, Moreno M U,et al. Gene expression profiling in whole blood of patients with coronary artery disease [J]. Clin Sci (Lond) ,2010,119:335-343.
  • 9Wu W H, Hu C P, Chen X P, Zhang W F, Li X W, Xiong X M, et al. MicroRNA-130a mediates prolifera- tion of vascular smooth muscle cells in hypertension [J]. Am J Hypertens, 2011,24 : 1087-1093.
  • 10Sasahira T, Kurihara M, Bhawal U K, Ueda N, Shimo- moto T, Yamamoto K, et al. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activa- tion of VEGF-A in oral cancer[J]. Br J Cancer, 2012, 107:700-706.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部